Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF
Clinical trial NCT02007720 · TERMINATED
Trial details
- NCT number
- NCT02007720
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-12
- Primary completion
- 2017-03-27
- Enrollment
- 876
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.